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Missense Makes Sense
In 1967, Bart and Pumphrey, a dermatologist–otolaryngologist team,
described an autosomal dominant disorder of syndromic hearing loss (SHL),
palmoplantar keratoderma, knuckle pads, and leukonychia. Richard and co-
workers now report about N54K, a novel GJB2 mutation affecting the gap junction
protein connexin-26, segregating in a family with Bart–Pumphrey Syndrome. Their
results show that these mutations are responsible for at least five overlapping
dermatologic disorders associated with SHL. Thus, 37 years after the recognition of
this rare syndrome, molecular evidence now supports the hypothesis of a single
genetic defect with a wide range of severity and organ involvement. J Invest Dermatol 123:856–863, 2004.
Redhead Receptors
Maybe Charlie Brown’s unrequited love interest, the Little Red-haired Girl, had a loss-
of-function mutation in the melanocortin (MC) 1 receptor. Redheads have an increased
ratio of pheomelanin to eumelanin. Pheomelanin is overproduced when a-melanocyte
stimulating hormone is absent or inhibited. Ringholm and colleagues investigated four
human MC1 receptor subtypes to determine their ability to bind a-MSH peptides and
increase intracellular cAMP. TheVal92Met mutant, present in the red-haired phenotype,
bound a-MSH with 100-fold lower affinity than the wild type MC1 receptor. The study’s
results provide important pharmacologic characterization insights for common MC1-
receptor variants in many of the world’s populations. J Invest Dermatol 123:917–923,
2004.
Imaging in vivo Injuries
Pan and coworkers investigated a healing wound in the skin of live
transgenic mice expressing the Yellow Fluorescent Protein (YFP) to
analyze epithelial responses to injury. YFP, regulated by an element from
the thy1 gene, was activated in all epidermal layers. YFP fluorescence –
representing the protein’s upregulation in keratinocytes – increased so
dramatically around the wound that the response was clearly visible. This
expression was also later provoked by a chemical irritant and suppressed
by topical hydrocortisone. This serendipitous discovery provides the means to monitor cutaneous responses to trauma in vivo
and to test agents that might affect epidermal wound healing. J Invest Dermatol 123:888–891, 2004.
Offense by Defense
Toxic epidermal necrolysis (TEN) is a rare adverse drug reaction with a high mortality rate. Nassif and coworkers compared
fluid from blisters in 13 TEN patients to burn blister fluids from controls. The TEN blister fluid had high concentrations of
several cytokines, but only IFN-gamma and, to some extent, IL-18 were produced by mononuclear cells present in the fluid.
They hypothesize that the other cytokines (TNF-alpha, sFas-L, IL-10) were produced as a defense mechanism by epidermal
cells against drug-specific cytotoxic (CD8) T-lymphocytes. The CTLs secrete IFN-gamma that activates keratinocytes and
ultimately leads to massive apoptosis. J Invest Dermatol 123:850–855, 2004.
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